3-Bromo-4-(propan-2-yloxy)aniline hydrochloride, 95%, 100g

5-(2-ethoxyphenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 2g

GC capillary column ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

Piperazine Dihydrobromide>98.0%(N)(T)5g

(6-(Methylsulfonyl)pyridin-3-yl)boronic acid, 95.0%, 5g

n-(Tert-butyl)-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 5g

(2-Bromophenylethynyl)trimethylsilane, 98%, 25g

Tert-butyl n-(4-amino-2-methoxyphenyl)carbamate, 97%, 5g

2-Acetamido-3-(thiophen-2-yl)propanoic acid, 97.0%, 1g

2-amino-9H-fluoren-9-one, 95.0%, 5g

ETHYL 2-(3-BROMOPHENYL)-2,2-DIFLUOROACETATE, 95%, 10g

tert-butyl 2-methyl-3-{[(4-methylphenyl)methyl]amino}propanoate, 95.0%, 2g

1-[3,5-Bis(trifluoromethyl)phenyl]-2-thiourea, 98.0%, 5g